1.
|
|
2.
|
|
3.
|
10 p, 8.9 MB |
Humoral Responses and Ex Vivo IFN-γ Production after Canine Whole Blood Stimulation with Leishmania infantum Antigen or KMP11 Recombinant Protein
/
Martínez-Orellana, Pamela (Universitat Autònoma de Barcelona. Departament de Medicina i Cirurgia Animals) ;
González, Noemí (Universitat Autònoma de Barcelona. Departament de Medicina i Cirurgia Animals) ;
Baldassarre, Antonella (Università degli Studi di Bari Aldo Moro. Dipartimento delle Emergenze e dei Trapianti d' Organo) ;
Álvarez-Fernández, Alejandra (Universitat Autònoma de Barcelona. Departament de Medicina i Cirurgia Animals) ;
Ordeix, Laura (Universitat Autònoma de Barcelona. Departament de Medicina i Cirurgia Animals) ;
Paradies, Paola (Università degli Studi di Bari Aldo Moro. Dipartimento delle Emergenze e dei Trapianti d' Organo) ;
Soto, Manuel (Universidad Autónoma de Madrid, Departamento de Biología Molecular) ;
Solano Gallego, Laia (Universitat Autònoma de Barcelona. Departament de Medicina i Cirurgia Animals)
The effect of Leishmania infantum soluble antigen (LSA) and recombinant Kinetoplastid Membrane Protein 11 (rKMP11) on the induction of ex vivo specific IFN-γ (n = 69) and antibody responses (n = 108) was determined in dogs. [...]
2022 - 10.3390/vetsci9030116
Veterinary Sciences, Vol. 9 Núm. 3 (2022) , p. 116
|
|
4.
|
|
5.
|
|
6.
|
|
7.
|
11 p, 5.4 MB |
Bartonella henselae Antibodies in Serum and Oral Fluid Specimens from Cats
/
Álvarez-Fernández, Alejandra (Universitat Autònoma de Barcelona. Departament de Medicina i Cirurgia Animals) ;
Breitschwerdt, Edward (North Carolina State University. Department of Clinical Sciences) ;
Solano Gallego, Laia (Universitat Autònoma de Barcelona. Departament de Medicina i Cirurgia Animals) ;
Baxarias, Marta (Universitat Autònoma de Barcelona. Departament de Medicina i Cirurgia Animals) ;
Prandi Chevalier, David (Universitat Autònoma de Barcelona. Departament de Medicina i Cirurgia Animals)
Cats are the primary reservoir host for Bartonella henselae(B. henselae), an etiological agent of human bartonellosis, including cat scratch disease. Although Bartonella DNA has been amplified from salivary swabs from cats, dogs and humans, we are not aware of studies investigating Bartonella antibodies in oral fluid (OF). [...]
2021 - 10.3390/pathogens10030329
Pathogens, Vol. 10 Núm. 3 (2021) , p. 329
|
|
8.
|
6 p, 1.4 MB |
Improved Alere Determine Lipoarabinomannan Antigen Detection Test for the Diagnosis of Human and Bovine Tuberculosis by Manipulating Urine and Milk
/
García, Juan Ignacio (Universitat Autònoma de Barcelona. Departament de Pediatria, d'Obstetrícia i Ginecologia i de Medicina Preventiva) ;
Kelley, Holden V. (Texas Biomedical Research Institute) ;
Meléndez, Johanna (Roosevelt Hospital) ;
Álvarez de León, Rosa Alejandra (Roosevelt Hospital) ;
Castillo, Alejandra (Clinica de Atención Integral Dr. Isaac Cohen Alcahe. Hospital de Especialidad Dr. Robles) ;
Sidiki, Sabeen (Ohio State University) ;
Yusoof, Kizil A. (Texas Biomedical Research Institute) ;
Nunes, Elizabete (Hospital Central de Maputo. Division of Pulmonology) ;
López Téllez, César (Clinica de Atención Integral Dr. Isaac Cohen Alcahe. Hospital de Especialidad Dr. Robles) ;
Mejía Villatoro, Carlos Rodolfo (Roosevelt Hospital) ;
Ikeda, Janet (Investigación, Desarrollo y Educación Integral (Quetzaltenango, Guatemala)) ;
García-Basteiro, Alberto L.. (Amsterdam Institute for Global Health and Development) ;
Wang, Shu Hua (Ohio State University) ;
Torrelles, Jordi B. (Texas Biomedical Research Institute)
Tuberculosis (TB) disease still kills 1-person every 21-seconds. Few TB diagnostic tests are considered truly appropriate for point of care settings. The WHO-endorsed immunodiagnostic Alere Determine Lipoarabinomannan Ag-test (LAM-test) detects Mycobacterium tuberculosis complex LAM in urine, and its use is recommended for TB diagnosis among HIV co-infected individuals with low CD4 T-cell counts. [...]
2019 - 10.1038/s41598-019-54537-9
Scientific reports, Vol. 9 Núm. 1 (january 2019) , p. 18012
|
|
9.
|
9 p, 632.8 KB |
Human Albumin Impairs Amyloid β-peptide Fibrillation Through its C-terminus : From docking Modeling to Protection Against Neurotoxicity in Alzheimer's disease
/
Picón-Pagès, Pol (Universitat Pompeu Fabra. Laboratori de Fisiologia Molecular) ;
Bonet, Jaume (Universitat Pompeu Fabra. Grup de Recerca en Bioinformàtica Estructural) ;
García-García, Javier (Universitat Pompeu Fabra. Grup de Recerca en Bioinformàtica Estructural) ;
Garcia-Buendia, Joan (Universitat Pompeu Fabra. Laboratori de Fisiologia Molecular) ;
Gutiérrez, Daniela (Pontificia Universidad Católica de Chile. Departamento de Biología Celular y Molecular) ;
Valle García, Javier (Universitat Pompeu Fabra. Grup de Recerca en Proteòmica i Química de Proteïnes) ;
Gómez-Casuso, Carmen E. S. (Universitat Pompeu Fabra. Laboratori de Fisiologia Molecular) ;
Sidelkivska, Valeriya (Universitat Pompeu Fabra. Laboratori de Fisiologia Molecular) ;
Alvarez, Alejandra (Pontificia Universidad Católica de Chile. Departamento de Biología Celular y Molecular) ;
Peralvarez-Marin, Alex (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ;
Suades, Albert (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ;
Fernàndez-Busquets, Xavier (Barcelona Institute for Global Health (ISGlobal)) ;
Andreu Martínez, David (Universitat Pompeu Fabra. Grup de Recerca en Proteòmica i Química de Proteïnes) ;
Vicente, Rubén (Universitat Pompeu Fabra. Laboratori de Fisiologia Molecular) ;
Oliva Miguel, Baldomero (Universitat Pompeu Fabra. Grup de Recerca en Bioinformàtica Estructural) ;
Muñoz, Francisco J. (Universitat Pompeu Fabra. Laboratori de Fisiologia Molecular)
Alzheimer's disease (AD) is a neurodegenerative process characterized by the accumulation of extracellular deposits of amyloid β-peptide (Aβ), which induces neuronal death. Monomeric Aβ is not toxic but tends to aggregate into β-sheets that are neurotoxic. [...]
2019 - 10.1016/j.csbj.2019.06.017
Computational and Structural Biotechnology Journal, Vol. 17 (2019) , p. 963-971
|
|
10.
|
12 p, 571.6 KB |
Randomized Controlled Trial Assessing the Impact of Tacrolimus Versus Cyclosporine on the Incidence of Posttransplant Diabetes Mellitus
/
Torres, Armando (Hospital Universitario de Canarias (La Laguna)) ;
Hernández, Domingo (Instituto de Investigación Biomédica de Málaga) ;
Moreso, Francesc (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Seron, Daniel (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Burgos, María Dolores (Instituto de Investigación Biomédica de Málaga) ;
Pallardó, Luis M. (Hospital Universitari Doctor Peset (València)) ;
Kanter, Julia (Hospital Universitari Doctor Peset (València)) ;
Díaz Corte, Carmen (Hospital Universitario Central de Asturias) ;
Rodríguez, Minerva (Hospital Universitario Central de Asturias) ;
Díaz Gómez, Juan Manuel (Institut d'Investigació Biomèdica Sant Pau) ;
Silva, Irene (Institut d'Investigació Biomèdica Sant Pau) ;
Valdes, Francisco (Complejo Hospitalario Universitario de A Coruña) ;
Fernández-Rivera, Constantino (Complejo Hospitalario Universitario de A Coruña) ;
Osuna, Antonio (Hospital Universitario Virgen de las Nieves (Granada)) ;
Gracia Guindo, María C. (Hospital Universitario Virgen de las Nieves (Granada)) ;
Gómez Alamillo, Carlos (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Ruiz, Juan C. (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Marrero Miranda, Domingo (Hospital Universitario de Canarias (La Laguna)) ;
Pérez-Tamajón, Lourdes (Hospital Universitario de Canarias (La Laguna)) ;
Rodríguez, Aurelio (Hospital Universitario de Canarias (La Laguna)) ;
González-Rinne, Ana (Hospital Universitario de Canarias (La Laguna)) ;
Alvarez, Alejandra (Hospital Universitario de Canarias (La Laguna)) ;
Perez-Carreño, Estefanía (Hospital Universitario de Canarias (La Laguna)) ;
de la Vega Prieto, María José (Hospital Universitario de Canarias (La Laguna)) ;
Henriquez, Fernando (Hospital Universitario de Gran Canaria Dr. Negrín) ;
Gallego Samper, Roberto (Hospital Universitario de Gran Canaria Dr. Negrín) ;
Salido, Eduardo (Hospital Universitario de Canarias (La Laguna)) ;
Porrini, Esteban (Hospital Universitario de Canarias (La Laguna)) ;
Universitat Autònoma de Barcelona
Despite the high incidence of posttransplant diabetes mellitus (PTDM) among high-risk recipients, no studies have investigated its prevention by immunosuppression optimization. We conducted an open-label, multicenter, randomized trial testing whether a tacrolimus-based immunosuppression and rapid steroid withdrawal (SW) within 1 week (Tac-SW) or cyclosporine A (CsA) with steroid minimization (SM) (CsA-SM), decreased the incidence of PTDM compared with tacrolimus with SM (Tac-SM). [...]
2018 - 10.1016/j.ekir.2018.07.009
Kidney International Reports, Vol. 3 (july 2018) , p. 1304-1315
|
|